Back Donate
Default image for pages

De Vries B, Stam AH, Beker F, Van den Maagdenberg AM, Vanmolkot KR, Laan L, Ginjaar IB, Frants RR, Lauffer H, Haan J, Haas JP, Terwindt GM. “CACNA1A Mutation Linking Hemiplegic Migraine and Alternating Hemiplegia of Childhood.” Cephalalgia 28, no. 8 (August 2008): 887-91.

Roubergue A, Philibert B, Gautier A, Kuster A, MarkowiczK, Billette de Villemeur T, Vuillaumier-Barrot S, Nicole S, Roze E, Doummar D. “Excellent Response to a Ketogenic Diet in a Patient with Alternating Hemiplegia of Childhood.” JIMD Reports 15 (2015): 7-12.

Gaul C, Kraya T, Holle D, Benkel-Herrenbruck I, Schara U, Ebinger F. “Migraine Variants and Unusual Types of Migraine in Childhood.” Schmerz (German) 25, no. 2 (April 2011): 148-156.

Kors E, VanMolkot K, Haan J, Kheradmand K, Stroink H, Laan L, Gill D, Pascual J, van den Maagdenberg A, Frants R. “Alternating Hemiplegia of Childhood: No Mutations in the Second Familial Hemiplegic Migraine Gene ATP1A2.” Neuropediatrics 35, no. 5 (October 2004): 293-296.

Lagman-Bartolome AM, Lay C. “Pediatric Migraine Variants: A Review of Epidemiology, Diagnosis, Treatment, and Outcome.” Curr Neurol Neurosci Rep. (April 24, 2015).

Kasinathan A, Sharawat IK, Sahu JK, Sankhyan N. “Topiramate Therapy in Alternating Hemiplegia of Childhood.” Indian Journal of Pediatrics. 2017 Dec; 84;(12): 957-958.

Kwon YJ, Falk MJ, Bennett MJ. “Flunarizine rescues reduced Lifespan in CLN3 Triple Knock-out Caenorhabditis Elegans Model of Batten Disease.” Journal of Inherited Metabolic Disease (October 20, 2016).

Lai KL, Niddam DM, Fuh JL, Chen SP, Wang YF, Chen WT, Wu JC, Wang SJ. “Flunarizine Versus Topiramate for Chronic Migraine Prophylaxis: A Randomized Trial.” Acta Neurologica Scandinavica (June 16, 2016).

Mohamed BP, Goadsby J, Prabhakar P. “Safety and Efficacy of Flunarizine in Childhood Migraine: 11 Years’ Experience, with Emphasis on its Effect in Hemiplegic Migraine.” Developmental Medicine & Child Neurology (January 23, 2012).

Pledger GW. “Flunarizine for Treatment of Partial Seizures: Results of a Concentration-Controlled Trial.” Neurology 44, no.10 (1994): 1830-1836.